135 related articles for article (PubMed ID: 36252636)
1. Osteoradionecrosis rate in oropharynx cancer treated with dose volume histogram based constraints.
Lee CT; Litwin S; Yao CMKL; Liu JC; Ridge JA; Galloway TJ
Radiother Oncol; 2022 Nov; 176():215-221. PubMed ID: 36252636
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer patients.
Lee IJ; Koom WS; Lee CG; Kim YB; Yoo SW; Keum KC; Kim GE; Choi EC; Cha IH
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1084-91. PubMed ID: 19327914
[TBL] [Abstract][Full Text] [Related]
3. Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison.
MD Anderson Head and Neck Cancer Symptom Working Group
Radiother Oncol; 2017 Aug; 124(2):232-239. PubMed ID: 28733053
[TBL] [Abstract][Full Text] [Related]
4. Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer.
Tsai CJ; Hofstede TM; Sturgis EM; Garden AS; Lindberg ME; Wei Q; Tucker SL; Dong L
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):415-20. PubMed ID: 22795804
[TBL] [Abstract][Full Text] [Related]
5. Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations.
Aarup-Kristensen S; Hansen CR; Forner L; Brink C; Eriksen JG; Johansen J
Acta Oncol; 2019 Oct; 58(10):1373-1377. PubMed ID: 31364903
[No Abstract] [Full Text] [Related]
6. Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.
Caparrotti F; Huang SH; Lu L; Bratman SV; Ringash J; Bayley A; Cho J; Giuliani M; Kim J; Waldron J; Hansen A; Tong L; Xu W; O'Sullivan B; Wood R; Goldstein D; Hope A
Cancer; 2017 Oct; 123(19):3691-3700. PubMed ID: 28608925
[TBL] [Abstract][Full Text] [Related]
7. Empirical Relative Biological Effectiveness (RBE) for Mandible Osteoradionecrosis (ORN) in Head and Neck Cancer Patients Treated With Pencil-Beam-Scanning Proton Therapy (PBSPT): A Retrospective, Case-Matched Cohort Study.
Yang Y; Muller OM; Shiraishi S; Harper M; Amundson AC; Wong WW; McGee LA; Rwigema JM; Schild SE; Bues M; Fatyga M; Anderson JD; Patel SH; Foote RL; Liu W
Front Oncol; 2022; 12():843175. PubMed ID: 35311159
[TBL] [Abstract][Full Text] [Related]
8. Development of a local dose-response relationship for osteoradionecrosis within the mandible.
Sijtsema ND; Verduijn GM; Nasserinejad K; van Norden Y; Mast H; van der Lugt A; Hoogeman MS; Petit SF
Radiother Oncol; 2023 Sep; 186():109736. PubMed ID: 37315578
[TBL] [Abstract][Full Text] [Related]
9. Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions.
Ben-David MA; Diamante M; Radawski JD; Vineberg KA; Stroup C; Murdoch-Kinch CA; Zwetchkenbaum SR; Eisbruch A
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):396-402. PubMed ID: 17321069
[TBL] [Abstract][Full Text] [Related]
10. Extra-mandibular Osteoradionecrosis after the Treatment of Head and Neck Cancer.
Kovarik PDE; Patil R; Cvek J; Kelly C; Jackson M; Mackenzie L; West N; Willis N; Kovarik JP; Banks R; Kennedy M; Adams J; Iqbal MS
Clin Oncol (R Coll Radiol); 2023 Sep; 35(9):e498-e505. PubMed ID: 37433701
[TBL] [Abstract][Full Text] [Related]
11. Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: A retrospective cohort study.
Möring MM; Mast H; Wolvius EB; Verduijn GM; Petit SF; Sijtsema ND; Jonker BP; Nout RA; Heemsbergen WD
Oral Oncol; 2022 Oct; 133():106056. PubMed ID: 35933938
[TBL] [Abstract][Full Text] [Related]
12. Risk profile for osteoradionecrosis of the mandible in the IMRT era.
Studer G; Bredell M; Studer S; Huber G; Glanzmann C
Strahlenther Onkol; 2016 Jan; 192(1):32-9. PubMed ID: 26265308
[TBL] [Abstract][Full Text] [Related]
13. Osteoradionecrosis following treatment for head and neck cancer and the effect of radiotherapy dosimetry: the Guy's and St Thomas' Head and Neck Cancer Unit experience.
De Felice F; Thomas C; Patel V; Connor S; Michaelidou A; Sproat C; Kwok J; Burke M; Reilly D; McGurk M; Simo R; Lyons A; Oakley R; Jeannon JP; Lei M; Urbano TG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Jul; 122(1):28-34. PubMed ID: 27039003
[TBL] [Abstract][Full Text] [Related]
14. Analysis of mandibular dose distribution in radiotherapy for oropharyngeal cancer: dosimetric and clinical results in 18 patients.
Jereczek-Fossa BA; Garibaldi C; Catalano G; d'Onofrio A; De Pas T; Bocci C; Ciocca M; DePaoli F; Orecchia R
Radiother Oncol; 2003 Jan; 66(1):49-56. PubMed ID: 12559520
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of osteoradionecrosis of the mandible.
Boromand G; Haugen-Cange H; Asparusova M; Ekestubbe A; Kjeller G
Acta Odontol Scand; 2024 Jan; 82(1):48-54. PubMed ID: 37772879
[TBL] [Abstract][Full Text] [Related]
17. Dose volume histogram constraints in patients with head and neck cancer treated with surgery and adjuvant HDR brachytherapy: A proposal of the head and neck and skin GEC ESTRO Working group.
García-Consuegra A; Gimeno Morales M; Cambeiro M; Tagliaferri L; Kovacs G; Van Limbergen E; Ramos LI; Manuel Arnaiz J; Alcalde J; Lecanda F; Martinez-Monge R
Radiother Oncol; 2021 Jan; 154():128-134. PubMed ID: 32941955
[TBL] [Abstract][Full Text] [Related]
18. Frequency of osteoradionecrosis of the lower jaw after radiotherapy of oral cancer patients correlated with dosimetric parameters and other risk factors.
Lang K; Held T; Meixner E; Tonndorf-Martini E; Ristow O; Moratin J; Bougatf N; Freudlsperger C; Debus J; Adeberg S
Head Face Med; 2022 Feb; 18(1):7. PubMed ID: 35219324
[TBL] [Abstract][Full Text] [Related]
19. Is Dose Volume a Better Predictor of Osteoradionecrosis Risk Than Total Dose for Patients Who Have Received Head and Neck Radiation?
DeLuke D; Carrico C; Ray C; Stilianoudakis S; Holler S; Padilla L; Song S
J Oral Maxillofac Surg; 2022 Sep; 80(9):1557-1563. PubMed ID: 35594907
[TBL] [Abstract][Full Text] [Related]
20. The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience.
Owosho AA; Tsai CJ; Lee RS; Freymiller H; Kadempour A; Varthis S; Sax AZ; Rosen EB; Yom SK; Randazzo J; Drill E; Riedel E; Patel S; Lee NY; Huryn JM; Estilo CL
Oral Oncol; 2017 Jan; 64():44-51. PubMed ID: 28024723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
